Lv1
60 积分 2025-12-12 加入
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
2小时前
待确认
European Study of Prostate Cancer Screening — 23-Year Follow-up
5小时前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
7天前
已完结
Granulomatosis with Polyangiitis
7天前
已完结
Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial
8天前
已完结
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
10天前
已完结
Trends and mechanisms of Alzheimer's disease and hearing impairment: A 20-year perspective
11天前
已完结
First robot‐assisted radical prostatectomy in a client‐owned Bernese mountain dog with prostatic adenocarcinoma
11天前
已完结
Looking to the Future; Veterinary Robotic Surgery
11天前
已完结
Serogroup Switching in Neisseria meningitidis with Dual Antibiotic Resistance
13天前
已完结
皖公网安备34019202002308
